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| I NTR OD U CTI ON
The Fontan circulation procedure has provided lifesaving palliation for individuals born with single ventricle physiology, with survival outcomes of 76% at 25 years of age. 1 However, adverse medical outcomes (eg, liver dysfunction, heart failure, arrhythmia, hemodynamic abnormalities) [2] [3] [4] [5] and functional limitations (eg, exercise intolerance, employment restrictions) 6, 7 have been well documented. In recognition of the potential challenges of living with a Fontan circulation, there has been increasing attention in recent years to patient-reported outcomes, including quality of life (QOL). Research regarding QOL among Fontan patients has produced mixed results (depending on sample characteristics and QOL definitions), with some studies reporting lower levels of QOL relative to healthy controls 4, 8 and others finding no differences. 9, 10 However, most studies suggest that average QOL is relatively high in this population despite the medical outcomes and functional complications of life with a Fontan circulation. 6, 7, 9, 11 Still, it is imperative to recognize the variability in QOL within this population. 4, 6, 10 HOLBEIN ET AL.
| 393
Approximately 26% of patients in one study reported dissatisfaction with their lives, 7 and 42% of young adults in another investigation endorsed total QOL scores in the impaired range. 8 Thus, while Fontan patients on average tend to report relatively good QOL, there is a substantial subset of patients who experience suboptimal outcomes. It is imperative to identify patient characteristics that explain this variability so appropriate treatment can be provided.
Illness perceptions, namely the beliefs patients have about their disease, 12 may explain some of the variability in QOL. Illness perceptions provide a framework for managing and coping with chronic health issues; examples include personal control over the illness, perceived treatment benefits, and effect of the illness on emotional functioning. 13 The link between negative illness perception scores and lower QOL has previously been demonstrated in congenital heart disease (CHD), 11, 14, 15 but not specifically within the Fontan population. Illness perceptions may be of particular significance for Fontan patients because individuals with more complex defects, including single ventricle physiology, tend to endorse beliefs of more severe health consequences, have a poorer understanding of their illness, and report more negative emotions. 14 While these perceptions may be considered more "negative" in comparison with those of patients with less complex defects, they likely are an appropriate reflection of the experiences of living with a complex heart defect.
14 Although illness perceptions have been found to mediate the association between condition complexity and QOL outcomes in patients with acquired heart disease, 16 there have been no comparable mediational studies in CHD. Identification of mechanisms that affect QOL is necessary to develop and implement interventions that target QOL improvements. Further, it is helpful to understand the Fontan experience relative to patients with other, less complex defects, such as atrial septal defects (ASD) and ventricular septal defects (VSD).
In the present study, we examined QOL and illness perceptions in a 
| Procedures
The APPROACH-IS study design and data collection procedures were previously reported by Apers et al. 18 Prior to data collection, 20 Items capture global life satisfaction and are scored on a 5-point Likert-type scale (eg, 1-strongly disagree to 7-strongly agree).
Higher scores indicate greater QOL. Internal consistency in the present study was excellent (Cronbach's a 5 .87).
Illness perceptions were assessed by the Brief Illness Perception
Questionnaire (Brief IPQ). 13 The nine-item Brief IPQ has demonstrated strong psychometric properties. 13 Items are rated from 0 to 10 and assess illness consequences, experience of symptoms ("identity"), expected duration of illness ("time line"), personal control, belief of treatment effectiveness ("treatment control"), concern, understanding of one's illness, and experience of distressing emotions ("emotional response"). An item measuring perceived causal factors of illness was not included in the larger study because it is not relevant to CHD. Although the measure was initially validated at the item-level 13 and utilized as such in CHD research, 14, 15 cardiac researchers have also used a composite illness perceptions total score. 16 The total score was used to test each hypothesis while exploratory analyses utilized item-level data. Higher values indicate more positive illness perceptions. After reverse-scoring six items, items were averaged to compute a total score (Cronbach's a 5 .64).
| Covariates
Symptoms of depression and anxiety were assessed by the Hospital Anxiety and Depression Scale (HADS). 21 The questionnaire yields two 7-item subscales for anxiety and depressive symptoms, with each scale ranging from 0 to 21; a score 8 indicates clinically significant symptoms. Internal consistency for the anxiety and depression subscales in this study were Cronbach's a 5 .82 and .78, respectively.
Participants provided self-report of their NYHA functional class by answering one item asking them to rate their physical limitations on a 4-point scale ranging from I (no limitations during physical activities) to 4 (unable to be physically active without experiencing physical discomfort).
| Statistical methods
Descriptive statistics and bivariate correlations were conducted to provide additional information about study variables. One-way analyses of covariance (ANCOVAs) examined differences in QOL and illness perceptions between Fontan patients versus those with ASD/VSD. Age, sex, and country of residence were included as covariates due to significant group differences as well as existing evidence-based associations with QOL. 17, 19 Analyses were conducted in Mplus 22 to appropriately manage both missing data and nonnormal data. Exploratory analyses included examination of item-level differences in illness perceptions between the two samples. All a priori pairwise comparisons (ie, comparing samples on each IPQ item) with covariates were run using a multigroup function in Mplus. A false discovery rate (FDR) 23 Type I error control was utilized for all pairwise illness perception comparisons.
Analyses testing whether illness perceptions mediated the association between CHD diagnosis and QOL were also run in MPlus. In addition to demographic covariates, NYHA functional status, and anxiety and depressive symptoms were included as covariates due to previously demonstrated associations with QOL and illness perceptions. 11, 17 Direct and indirect (ie, mediated) effects were assessed by evaluation of 95% confidence intervals produced by bootstrapping (bootstrapping 5 1000). Model fit was assessed using four indicators:
chi-square, standardized root mean square residual (SRMR), comparative fit index (CFI), and root mean square error of approximation (RMSEA). Following identification of the mediated effect, age and sex were examined as moderators of the mediation model. Country of residence was not examined as a moderator due to small sample sizes within some countries. Missing data was handled using maximum likelihood estimate algorithms (ie, MLR for ANCOVA and pair-wise comparisons; MLE for mediation analyses) in Mplus.
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| Correlations
Bivariate Pearson and point-biserial correlations are presented in Table   2 . Higher QOL was associated with more positive illness perceptions and lower anxiety symptoms, depressive symptoms, and functional class. Total illness perceptions were also inversely correlated with anxiety and depressive symptoms as well as NYHA functional class. Neither age nor sex were significantly associated with either illness perceptions or QOL, although older age was associated with lower anxiety and lower NYHA functional class for the whole sample. 
| Exploratory analyses: Group differences in illness perceptions
Results from multigroup analyses with covariates are presented in Overall, results suggest that CHD diagnosis influences illness perception scores, which are then important contributors to QOL.
As age and sex differences were present between the Fontan and ASD/VSD samples, these variables were examined as moderators of the mediated associations. Moderated mediation models were tested, such
that age and sex were tested as moderators and removed as model covariates. Neither of the moderated mediation models produced significant effects, suggesting that the association between CHD diagnosis, illness perceptions, and QOL does not differ as a function of age or sex.
| D I SCUSSION
In the present study, we found that patients with a Fontan circulation reported lower QOL and more negative illness perception scores than patients with isolated ASD/VSD. Illness perceptions also mediated the association between CHD diagnosis and QOL. In other words, the patient's defect was associated with his or her perceptions of CHD, which in turn was related to QOL. This finding was consistent regardless of age or sex. Strengths of this study include a large multinational sample, use of a comparison sample, and the use of previous findings to drive study hypotheses.
Consistent with the proposed hypotheses, Fontan patients reported lower QOL relative to patients with less complex defects; this underscores prior studies demonstrating that more complex defects are associated with lower QOL. 19, 24, 25 It is possible that ASD/VSD patients included in APPROACH-IS may have experienced greater CHD severity than the overall ASD/VSD population given the fact that they were followed at a tertiary care center. Thus, the true differences between Fontan and ASD/VSD patients followed in the community may be even larger. Still, similar to prior research, 10, 26 Fontan patients in the current study reported relatively high QOL; these high ratings of QOL suggest that many patients with Fontan circulations demonstrate resilience, despite the medical and psychosocial implications of living with complex CHD. [2] [3] [4] 27 The chronic illness literature suggests that resilience (ie, the ability to adapt well despite adversity) results from the dynamic interplay of genetic (eg, temperament, HPA axis regulation), environmental (eg, social support), and individual factors (eg, self-efficacy, spirituality). 28 Future research may investigate specific contributors to resiliency specific to adults with CHD. or difficulty coping with CHD may be referred for mental health intervention, 31, 32 including cognitive behavioral therapy, artistic therapies, spiritual counseling, and peer-to-peer support programs. 33 In fact, a previous study revealed that one third of surveyed patients expressed interest in learning stress management and coping skills related to CHD. 27 It is important to investigate whether the modification of ill- American countries, it is essential for future patient-reported outcomes research to include participants from these under-represented areas. 
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